Hims & Hers rolls out weight-loss shots much cheaper than Ozempic, Wegovy
Health and wellness company Hims & Hers announced Monday that it is introducing injectable weight-loss drugs at a fraction of the cost of Ozempic and Wegovy.
Hims & Hers stock slides after CEO's praise for anti-Israel protesters
Hims & Hers Health stock declined Friday by about 8% after CEO Andrew Dudum's praise for anti-Israel campus protesters in a social media post last week.
Hims founder offers jobs to anti-Israel protesters, hails their 'moral courage'
Hims & Hers CEO Andrew Dudum said in a social media post that anti-Israel campus protesters are making a difference and that his company and others will hire them.